Watchlist
Loading...
HSI16425.68+97.82 +0.60%HSCEI5649.89+40.26 +0.72%HSTECH3729.81+47.14 +1.28%
HK Stock MarketDetailed Quotes

01801 INNOVENT BIO

Watchlist
40.250 -1.350-3.25%
Trading 12/06 15:43 CST
41.600High39.650Low9.51MVolume

INNOVENT BIO Key Stats

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)2023/06/30
(FY)2022/12/31
(Q6)2022/06/30
(FY)2021/12/31
(Q6)2021/06/30
(FY)2020/12/31
(Q6)2020/06/30
(FY)2019/12/31
(Q6)2019/06/30
(FY)2018/12/31
Turnover
20.63%2.7B
6.71%4.56B
15.34%2.24B
11.08%4.27B
97.29%1.94B
266.94%3.84B
184.85%984.21M
10,953.34%1.05B
7,688.93%345.52M
-48.88%9.48M
Operating income
20.63%2.7B
6.71%4.56B
15.34%2.24B
11.08%4.27B
97.29%1.94B
266.94%3.84B
184.85%984.21M
10,953.34%1.05B
7,688.93%345.52M
-48.88%9.48M
Cost of sales
-7.02%-504.62M
-84.23%-930.99M
-117.42%-471.53M
-30.32%-505.34M
-17.35%-216.88M
-210.51%-387.76M
-351.30%-184.82M
---124.88M
---40.95M
----
Operating expenses
-7.02%-504.62M
-84.23%-930.99M
-117.42%-471.53M
-30.32%-505.34M
-17.35%-216.88M
-210.51%-387.76M
-351.30%-184.82M
-124.88M
-40.95M
Gross profit
24.26%2.2B
-3.69%3.63B
2.50%1.77B
8.92%3.76B
115.77%1.72B
274.58%3.46B
162.47%799.39M
9,635.64%922.65M
6,765.76%304.57M
9.48M
Selling expenses
3.61%-1.35B
1.12%-2.59B
-28.93%-1.4B
-95.41%-2.62B
-142.76%-1.08B
-93.62%-1.34B
-67.45%-446.62M
-409.18%-692.52M
-2,542.37%-266.72M
-1,542.98%-136.01M
Administrative expenses
9.66%-368.39M
-3.66%-835.49M
-32.46%-407.8M
-84.50%-806.01M
-64.78%-307.87M
-71.12%-436.87M
-139.19%-186.84M
-15.88%-255.3M
-6.84%-78.11M
-177.16%-220.32M
Research and development expenses
21.43%-922.82M
-23.63%-2.87B
-20.54%-1.17B
-25.44%-2.32B
-20.59%-974.32M
-43.00%-1.85B
-20.46%-807.95M
-5.98%-1.29B
-59.68%-670.7M
-99.65%-1.22B
Special items of operating profit
-8.48%235.89M
201.40%603.31M
176.99%257.73M
3.61%-594.98M
-578.42%-334.75M
-81.24%-617.24M
110.16%69.97M
91.96%-340.57M
-92.98%33.29M
-19,070.22%-4.24B
Operating profit
78.43%-205.82M
19.79%-2.07B
2.25%-954.35M
-226.34%-2.58B
-70.67%-976.3M
52.40%-790.36M
15.59%-572.05M
71.39%-1.66B
-2,644.94%-677.67M
-780.96%-5.8B
Financing cost
-12.85%-50.29M
-62.81%-101.7M
-64.43%-44.57M
8.61%-62.46M
16.89%-27.1M
-14.89%-68.35M
11.22%-32.61M
13.74%-59.49M
-11.63%-36.73M
-20.52%-68.97M
Earning before tax
74.36%-256.11M
17.84%-2.17B
0.45%-998.91M
-207.64%-2.64B
-65.94%-1B
50.07%-858.71M
15.36%-604.67M
70.71%-1.72B
-1,140.37%-714.41M
-720.19%-5.87B
Tax
141.43%116.96M
89.89%-8.8M
31,971.05%48.44M
37.70%-87.04M
95.69%-152K
---139.71M
---3.53M
----
----
----
After-tax profit from continuing operations
85.36%-139.15M
20.14%-2.18B
5.29%-950.47M
-173.31%-2.73B
-65.01%-1B
41.95%-998.42M
14.87%-608.19M
70.71%-1.72B
-1,140.37%-714.41M
-720.19%-5.87B
Earning after tax
85.36%-139.15M
20.14%-2.18B
5.29%-950.47M
-173.31%-2.73B
-65.01%-1B
41.95%-998.42M
14.87%-608.19M
70.71%-1.72B
-1,140.37%-714.41M
-720.19%-5.87B
Minority profit
----
----
----
----
----
----
----
----
----
33.98%-101.49M
Profit attributable to shareholders
85.36%-139.15M
20.14%-2.18B
5.29%-950.47M
-173.31%-2.73B
-65.01%-1B
41.95%-998.42M
14.87%-608.19M
70.20%-1.72B
-1,727.57%-714.41M
-926.38%-5.77B
Basic earnings per share
86.15%-0.09
22.34%-1.46
5.80%-0.65
-154.05%-1.88
-50.00%-0.69
49.32%-0.74
25.81%-0.46
91.53%-1.46
-306.67%-0.62
-189.26%-17.24
Diluted earnings per share
86.15%-0.09
22.34%-1.46
5.80%-0.65
-154.05%-1.88
-50.00%-0.69
49.32%-0.74
25.81%-0.46
91.53%-1.46
47.01%-0.62
-189.26%-17.24
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
(Q6)2023/06/30(FY)2022/12/31(Q6)2022/06/30(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30(FY)2019/12/31(Q6)2019/06/30(FY)2018/12/31
Turnover 20.63%2.7B6.71%4.56B15.34%2.24B11.08%4.27B97.29%1.94B266.94%3.84B184.85%984.21M10,953.34%1.05B7,688.93%345.52M-48.88%9.48M
Operating income 20.63%2.7B6.71%4.56B15.34%2.24B11.08%4.27B97.29%1.94B266.94%3.84B184.85%984.21M10,953.34%1.05B7,688.93%345.52M-48.88%9.48M
Cost of sales -7.02%-504.62M-84.23%-930.99M-117.42%-471.53M-30.32%-505.34M-17.35%-216.88M-210.51%-387.76M-351.30%-184.82M---124.88M---40.95M----
Operating expenses -7.02%-504.62M-84.23%-930.99M-117.42%-471.53M-30.32%-505.34M-17.35%-216.88M-210.51%-387.76M-351.30%-184.82M-124.88M-40.95M
Gross profit 24.26%2.2B-3.69%3.63B2.50%1.77B8.92%3.76B115.77%1.72B274.58%3.46B162.47%799.39M9,635.64%922.65M6,765.76%304.57M9.48M
Selling expenses 3.61%-1.35B1.12%-2.59B-28.93%-1.4B-95.41%-2.62B-142.76%-1.08B-93.62%-1.34B-67.45%-446.62M-409.18%-692.52M-2,542.37%-266.72M-1,542.98%-136.01M
Administrative expenses 9.66%-368.39M-3.66%-835.49M-32.46%-407.8M-84.50%-806.01M-64.78%-307.87M-71.12%-436.87M-139.19%-186.84M-15.88%-255.3M-6.84%-78.11M-177.16%-220.32M
Research and development expenses 21.43%-922.82M-23.63%-2.87B-20.54%-1.17B-25.44%-2.32B-20.59%-974.32M-43.00%-1.85B-20.46%-807.95M-5.98%-1.29B-59.68%-670.7M-99.65%-1.22B
Special items of operating profit -8.48%235.89M201.40%603.31M176.99%257.73M3.61%-594.98M-578.42%-334.75M-81.24%-617.24M110.16%69.97M91.96%-340.57M-92.98%33.29M-19,070.22%-4.24B
Operating profit 78.43%-205.82M19.79%-2.07B2.25%-954.35M-226.34%-2.58B-70.67%-976.3M52.40%-790.36M15.59%-572.05M71.39%-1.66B-2,644.94%-677.67M-780.96%-5.8B
Financing cost -12.85%-50.29M-62.81%-101.7M-64.43%-44.57M8.61%-62.46M16.89%-27.1M-14.89%-68.35M11.22%-32.61M13.74%-59.49M-11.63%-36.73M-20.52%-68.97M
Earning before tax 74.36%-256.11M17.84%-2.17B0.45%-998.91M-207.64%-2.64B-65.94%-1B50.07%-858.71M15.36%-604.67M70.71%-1.72B-1,140.37%-714.41M-720.19%-5.87B
Tax 141.43%116.96M89.89%-8.8M31,971.05%48.44M37.70%-87.04M95.69%-152K---139.71M---3.53M------------
After-tax profit from continuing operations 85.36%-139.15M20.14%-2.18B5.29%-950.47M-173.31%-2.73B-65.01%-1B41.95%-998.42M14.87%-608.19M70.71%-1.72B-1,140.37%-714.41M-720.19%-5.87B
Earning after tax 85.36%-139.15M20.14%-2.18B5.29%-950.47M-173.31%-2.73B-65.01%-1B41.95%-998.42M14.87%-608.19M70.71%-1.72B-1,140.37%-714.41M-720.19%-5.87B
Minority profit ------------------------------------33.98%-101.49M
Profit attributable to shareholders 85.36%-139.15M20.14%-2.18B5.29%-950.47M-173.31%-2.73B-65.01%-1B41.95%-998.42M14.87%-608.19M70.20%-1.72B-1,727.57%-714.41M-926.38%-5.77B
Basic earnings per share 86.15%-0.0922.34%-1.465.80%-0.65-154.05%-1.88-50.00%-0.6949.32%-0.7425.81%-0.4691.53%-1.46-306.67%-0.62-189.26%-17.24
Diluted earnings per share 86.15%-0.0922.34%-1.465.80%-0.65-154.05%-1.88-50.00%-0.6949.32%-0.7425.81%-0.4691.53%-1.4647.01%-0.62-189.26%-17.24
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Buy
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >